Beth Z. Clark, MD

Associate Professor of Pathology, Magee-Womens Hospital Pathology

Dr. Clark is a member of the Division of Breast and Gynecologic Pathology.

Research Interests
  • Biomarker testing in breast cancer
  • Pathologic evaluation of neoadjuvant systemic therapy in breast cancer
  • High-risk lesions of the breast
Representative Publications

View Dr. Clark's publications on PubMed

  • Bhargava R, Clark BZ, Dabbs DJ. Breast Cancers With Magee Equations™ Score of Less Than 18, or 18-25 and Mitosis Score of 1, Do Not Require Oncotype DX® Testing: A Value Study. Am J Clin Pathol, 2019 Feb 4;151(3):316-323.
  • Clark BZ, Onisko A, Assylbekova B, Li X, Bhargava R, Dabbs DJ. Breast Cancer Global Tumor Biomarkers: A Quality Assurance Study of Intratumoral Heterogeneity. Mod Pathol, 2019 Mar;32(3):354-366.
  • Hugar SB, Bhargava R, Dabbs DJ, Davis KN, Zuley M, Clark BZ. Isolated Flat Epithelial Atypia of the Breast is Associated with a Low Risk of Upgrade at Excision. Am J Clin Pathol, 2019 Apr 2;151(5):511-515.
  • Bhargava R, Clark BZ, Carter GJ, Brufsky AM, Dabbs DJ. The healthcare values of the Magee Decision Algorithm: use of Magee Equations and mitosis score to safely forgo molecular testing in breast cancer. Mod Pathol 2020 Aug; 33(8):1562-1570. PMID: 32203092.